Advertisement
Screener

Citius Oncology, Inc. (CTOR) Shares Outstanding (Cover Page)

2.8 / 5 stars · 68/120 Roast Me

Citius Oncology, Inc. Shares Outstanding (Cover Page)

Citius Oncology, Inc. (CTOR) had Shares Outstanding (Cover Page) of 92.98 million shares as of 2026-08-13, per its 10-Q filed 2026-08-14.

Financial Statements › Notes › Cover Page

dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14

  • 2026-08-13: Entity Common Stock, Shares Outstanding 92.98M shares.
  • 2026-05-14: Entity Common Stock, Shares Outstanding 92.98M shares.
  • 2026-02-10: Entity Common Stock, Shares Outstanding 88.28M shares.
  • 2025-12-23: Entity Common Stock, Shares Outstanding 84.80M shares.
Period endEntity Common Stock, Shares Outstanding
2026-08-1392.98M shares
10-Q · filed 2026-08-14
2026-05-1492.98M shares
10-Q · filed 2026-05-15
2026-02-1088.28M shares
10-Q · filed 2026-02-13
2025-12-2384.80M shares
10-K · filed 2025-12-23
2025-08-1178.37M shares
10-Q · filed 2025-08-12
2025-05-0971.55M shares
10-Q · filed 2025-05-14
2025-02-1171.55M shares
10-Q · filed 2025-02-14
2024-12-1871.55M shares
10-K/A · filed 2025-01-27
2024-08-092.36M shares
10-Q · filed 2024-08-09
2024-05-206.65M shares
10-Q · filed 2024-05-20
2024-04-166.65M shares
10-K · filed 2024-04-16
2023-11-138.94M shares
10-Q · filed 2023-11-20
2023-08-168.94M shares
10-Q · filed 2023-08-16
2023-04-178.94M shares
10-K · filed 2023-04-17
2023-03-318.94M shares
10-Q · filed 2023-05-15
2022-11-308.94M shares
10-Q · filed 2022-11-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Anixa Biosciences Inc (ANIX)United States$0.096B
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
ProMIS Neurosciences Inc. (PMN)$0.102B
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
Rallybio Corp (RLYB)United States$0.089B
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Equillium, Inc. (EQ)United States$0.109B-11.27